ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,683Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 663

$412K Total Retail Price of All Prescriptions

Rank: 126 out of 663

466 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

8% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,059 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 424 383 1 1
LEVOTHYROXINE SODIUM 382 382 2 3
WARFARIN SODIUM 369 323 3 8
LISINOPRIL 360 329 4 2
FUROSEMIDE 236 221 5 7
HYDROCHLOROTHIAZIDE 203 201 6 12
POTASSIUM CHLORIDE 195 184 7 23
OMEPRAZOLE 183 171 8 4
METOPROLOL TARTRATE 172 153 9 11
METFORMIN HCL 169 154 10 9
AMLODIPINE BESYLATE 163 154 11 5
HYDROCODONE-ACETAMINOPHEN 148 140 S3 12 6
ALLOPURINOL 147 142 13 28
TRIAMTERENE-HCTZ 134 130 14 42
TRAMADOL HCL 123 113 15 17
ZOLPIDEM TARTRATE 114 110 16 16
MELOXICAM 102 97 17 61
IPRATROPIUM-ALBUTEROL 99 98 18 108
DONEPEZIL HCL 99 98 18 40
METOPROLOL SUCCINATE 90 89 20 25
SERTRALINE HCL 84 84 21 35
ATENOLOL 83 83 22 10
ATORVASTATIN CALCIUM 82 81 23 13
HYDRALAZINE HCL 80 72 24 101
LOVASTATIN 80 78 24 30
NYSTATIN 77 71 26 124
TAMSULOSIN HCL 75 73 27 24
ALENDRONATE SODIUM 75 69 27 15
CARVEDILOL 73 73 29 47
GLIMEPIRIDE 71 70 30 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 71 30 22
MIRTAZAPINE 68 68 32 52
PREDNISONE 66 48 33 39
LANTUS 66 65 33 48
CITALOPRAM HBR 65 61 35 18
BUSPIRONE HCL 63 63 36 206
ADVAIR DISKUS 60 46 37 53
PREMARIN 59 40 R 38 156
AMOX TR-POTASSIUM CLAVULANATE 57 49 39 193
GABAPENTIN 57 34 39 20
NAMENDA 52 52 41 57
DIGOXIN 50 50 42 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.